Uncategorized

April Barnado, MD, MSCI ’16: R01, Predicting risk of systemic autoimmune disease in patients with positive antinuclear antibodies

Apr. 12, 2022—

Timothy Girard, MD, MSCI ’07: Selecting Intermediate Respiratory Support Following Extubation in the Pediatric Intensive Care Unit

Apr. 7, 2022—

David Janz, MD, MSCI ’14: LCMC Health ICU doctor discusses pain and progress in the pandemic

Apr. 5, 2022—

Kalpana Manthiram, MD, MSCI ’14: Adaptive immunity against SARS-CoV-2 is persistent and robust in COVID-convalescent children

Apr. 5, 2022—

Jon Soslow, MD, MSCI ’14: Vanderbilt’s Duchenne Clinic first in Tennessee to be certified

Apr. 5, 2022—

Kristen Ciombor, MD, MSCI ’13: Leading Gastrointestinal Cancer Experts Discuss Targeted Therapies and Landscape of Treatment

Apr. 5, 2022—

Virtual Regression Modeling Strategies Short Course May 2022

Mar. 9, 2022—Regression Modeling Strategies Virtual Short Course 2022 Frank E. Harrell, Jr., Ph.D., Professor of Biostatistics May 10-13 2022, optional R Workshop May 9 See https://hbiostat.org/doc/rms/4day.html hbiostat.org @f2harrell The course includes statistical methodology, case studies, and use of the R statistical computing language. Emphasis is on developing predictive models, model validation, and quantifying...

Satya Das, MD, MSCI ’20: Clinical Score can guide PRRT therapy decisions for neuroendocrine tumors

Jan. 19, 2022—Clinical score can guide PRRT therapy decisions for neuroendocrine tumors Das S, Chauhan A, Du L, et al. External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy. JAMA Network Open. 2022;5(1):e2144170. doi:10.1001/jamanetworkopen.2021.44170

Andrea Ramirez, MD, MSCI ’11: You can help solve medicine’s “one-size-fits-all” problem. Here’s how.

Dec. 14, 2021—

Todd Rice, MD, MSCI ’05 expounds on why doctors see rise in RSV among adults, rather than children

Dec. 14, 2021—

« Previous Page